BCDAHealthcareNano-Cap

BioCardia, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for BioCardia, Inc. (BCDA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are BCDA insiders buying or selling?

BioCardia, Inc. insiders reported 123 open-market buys ($14.6M) and 3 sells ($79.3K) across 126 Form 4 filings — a net buying position of $14.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 20, 2026)

Total Form 4 filings
126
SEC EDGAR
Insider filers
10
Insider buys (123)
$14.6M
Insider sells (3)
$79.3K

Insider sentiment

Net buying

Net insider flow of $14.6M in net buying. 12 insider buys in the last 90 days.

Recent BCDA insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 20, 2026Peter AltmanPresident and CEOPurchase500$0.83$415
Jul 15, 2026Peter AltmanPresident and CEOPurchase4.3K$0.87$3.8K
Jul 10, 2026Peter AltmanPresident and CEOPurchase7.5K$0.96$7.2K
Jul 8, 2026Peter AltmanPresident and CEOPurchase5.4K$0.96$5.2K
Jun 24, 2026STERTZER SIMON HDirectorPurchase109.2K$0.95$103.6K
Jun 22, 2026Peter AltmanPresident and CEOPurchase2.3K$0.89$2.0K
Jun 9, 2026Peter AltmanPresident and CEOPurchase5.0K$0.85$4.3K
May 21, 2026Peter AltmanPresident and CEOPurchase1.7K$0.92$1.6K
May 19, 2026Peter AltmanPresident and CEOPurchase5.7K$0.92$5.2K
May 15, 2026Peter AltmanPresident and CEOPurchase5.1K$1.02$5.2K
Apr 29, 2026Peter AltmanPresident and CEOPurchase5.0K$1.11$5.5K
Apr 22, 2026Peter AltmanPresident and CEOPurchase1.0K$1.23$1.2K
Mar 27, 2026Peter AltmanPresident and CEOPurchase900$1.23$1.1K
Feb 4, 2026Peter AltmanPresident and CEOPurchase5.0K$1.13$5.7K
Jan 21, 2026Peter AltmanPresident and CEOPurchase900$1.33$1.2K
Dec 17, 2025Peter AltmanPresident and CEOPurchase1.1K$1.31$1.4K
Sep 23, 2025STERTZER SIMON HDirectorPurchase398.4K$1.25$498.0K
Sep 23, 2025Andrew Scott BlankDirectorPurchase288.0K$1.25$360.0K
Sep 23, 2025Peter AltmanPresident and CEOPurchase48.0K$1.25$60.0K
Aug 25, 2025Peter AltmanPresident and CEOPurchase700$1.83$1.3K
Aug 13, 2025Peter AltmanPresident and CEOPurchase100$1.83$183
Aug 12, 2025Peter AltmanPresident and CEOPurchase400$1.75$700.4
Aug 11, 2025Peter AltmanPresident and CEOPurchase1.7K$1.76$3.0K
Jul 3, 2025David McclungChief Financial OfficerPurchase4.8K$2.08$10.0K
Jul 3, 2025Peter AltmanPresident and CEOPurchase24.1K$2.08$50.0K

Showing the 25 most recent of 126 Form 4 filings for BioCardia, Inc..

Most active BCDA insiders

  • Peter Altman88 filings
  • STERTZER SIMON H20 filings
  • David Mcclung6 filings
  • Andrew Scott Blank4 filings
  • Phillip Frost MD ET AL3 filings

Ask anything about BCDA insider activity

Use Trabud's AI agent to query BioCardia, Inc.'s Form 4 history in plain English — "Show me BCDA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

BCDA insider trading FAQ

Are BioCardia, Inc. insiders buying or selling?

Across 126 SEC Form 4 filings, BioCardia, Inc. (BCDA) insiders reported 123 open-market purchases totaling $14.6M and 3 sales totaling $79.3K. That is a net buying position of $14.6M.

How many insiders trade BCDA stock?

10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BioCardia, Inc.. The most recent filing was accepted on Jul 20, 2026.

Where does Trabud get BCDA insider trading data?

All BCDA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content